Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
1.925
-0.110 (-5.41%)
Sep 16, 2026, 4:00 PM EDT - Market closed
Alector Revenue
Alector had revenue of $3.32M in the quarter ending June 30, 2026, a decrease of -57.84%. This brings the company's revenue in the last twelve months to $13.86M, down -82.91% year-over-year. In the year 2025, Alector had annual revenue of $21.05M, down -79.07%.
Revenue (ttm)
$13.86M
Revenue Growth
-82.91%
P/S Ratio
15.50
Revenue / Employee
$134,592
Employees
103
Market Cap
214.94M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.05M | -79.51M | -79.07% |
| Dec 31, 2024 | 100.56M | 3.50M | 3.60% |
| Dec 31, 2023 | 97.06M | -36.56M | -27.36% |
| Dec 31, 2022 | 133.62M | -73.47M | -35.48% |
| Dec 31, 2021 | 207.09M | 185.99M | 881.54% |
| Dec 31, 2020 | 21.10M | -121.00K | -0.57% |
| Dec 31, 2019 | 21.22M | -6.46M | -23.33% |
| Dec 31, 2018 | 27.68M | 23.94M | 641.02% |
| Dec 31, 2017 | 3.74M | 3.32M | 797.84% |
| Dec 31, 2016 | 416.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Compugen | 74.00M |
| Invivyd | 58.37M |
| Foghorn Therapeutics | 36.74M |
| ProQR Therapeutics | 21.05M |
| Whitehawk Therapeutics | 7.15M |
| Entrada Therapeutics | 4.69M |
| Cartesian Therapeutics | 1.48M |
ALEC News
- 1 day ago - Alector Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 6 days ago - Alector Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 6 days ago - Alector Slides: Corporate presentation - Filings
- 13 days ago - Alector to Participate in Upcoming Healthcare Conferences - GlobeNewsWire
- 5 weeks ago - Alector reports Q2 EPS (21c), consensus (23c) - TheFly
- 5 weeks ago - Alector Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Alector Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Alector Earnings release: Q2 2026 - Filings